💡 What You Need to Know Right Away
- Natural senolytics like fisetin and quercetin selectively eliminate "zombie cells" through anti-apoptotic pathway disruption, with fisetin identified as the most potent natural senolytic among 10 flavonoids tested.[Evidence: C][9]
- The first human clinical trial demonstrated that dasatinib plus quercetin reduced senescent cell markers by 35% in adipose tissue within just 11 days.[Evidence: B][1]
- Intermittent "hit-and-run" dosing (3 consecutive days per cycle) appears more effective than daily supplementation based on current clinical protocols.[Evidence: A][4]
- Procyanidin C1 from grape seed extended median post-treatment lifespan by 64.2% in aged mice, demonstrating significant longevity potential.[Evidence: C][8]
If you have been researching ways to support healthy aging, you have likely encountered the term "senolytics." These compounds represent one of the most exciting developments in longevity science. The global senolytic market reached $1.53 billion in 2024 and is projected to grow to $6.39 billion by 2030, reflecting intense scientific and consumer interest.
Natural senolytics are plant-derived compounds, primarily flavonoids, that selectively target and eliminate senescent cells. These "zombie cells" accumulate with age and release inflammatory proteins that damage surrounding tissues. By clearing these dysfunctional cells, natural senolytics may help restore tissue function and reduce age-related inflammation.
This guide examines what the research actually shows about natural senolytics, including which compounds have the strongest evidence, proper dosing protocols, safety considerations, and importantly, what remains unproven. You will learn how these compounds work, who may benefit, and when to consult a healthcare provider.
❓ Quick Answers
What are natural senolytics?
Natural senolytics are plant-derived compounds that selectively eliminate senescent cells, often called "zombie cells." The primary natural senolytics include fisetin (found in strawberries), quercetin (found in onions and apples), curcumin (from turmeric), and EGCG (from green tea). These flavonoids work by disrupting the survival pathways that keep damaged cells alive.[Evidence: A][3]
How do natural senolytics work?
Natural senolytics target multiple anti-apoptotic pathways including BCL-2, BCL-xL, PI3K/Akt, and HSP90 that senescent cells depend on for survival. By disrupting these pathways, senolytics trigger apoptosis (programmed cell death) specifically in senescent cells while sparing healthy cells. This selectivity occurs because senescent cells accumulate high levels of copper and iron, making them vulnerable to flavonoid-induced oxidative damage.[Evidence: A][4][7]
What foods contain natural senolytics?
Fisetin is found in strawberries (160 µg/g), apples, persimmons, and cucumbers. Quercetin occurs in onions, capers, apples, and berries. Curcumin comes from turmeric root. EGCG is concentrated in green tea. Procyanidin C1 is found in grape seeds. However, foods do not contain therapeutic doses. You would need to consume approximately 37 cups of strawberries daily to match a typical fisetin supplement dose.[Evidence: C][9]
Do natural senolytics really work?
Human clinical trials show promising results. The first human trial demonstrated that dasatinib plus quercetin reduced senescent cell markers by 35% in adipose tissue within 11 days.[Evidence: B][1] A systematic review found quercetin significantly improved cartilage health markers in osteoarthritis models.[Evidence: A][15] However, most human data comes from small, short-term trials, and long-term efficacy requires further study.
Are natural senolytics safe?
Clinical trials report natural senolytics as generally well-tolerated. In Phase 1 trials, adverse events were primarily mild-to-moderate, including sleep disturbances and anxiety.[Evidence: B][2] Dasatinib plus quercetin was safe in Alzheimer's patients over 12 weeks.[Evidence: B][13] However, senolytics may interact with medications and are not recommended during pregnancy. Always consult a healthcare provider before starting.
What is the recommended dosage for senolytics?
Human clinical trials have used quercetin at 1000-1250 mg daily combined with dasatinib 100 mg for 3 consecutive days per treatment cycle.[Evidence: B][1][2] The intermittent "hit-and-run" approach is preferred over daily dosing.[Evidence: A][4] Fisetin-only protocols in humans remain under investigation, with pilot studies using varying doses.
Natural Senolytics
Senolytics are compounds that selectively induce death in senescent cells—aged cells that stop dividing but refuse to die. Explore how nature's own molecules might hold the key to extending healthspan.
🔬 How Do Natural Senolytics Work?
To understand how natural senolytics work, think of senescent cells as retired employees who refuse to leave the office. They no longer do productive work, but they take up space, consume resources, and, worse, constantly complain to everyone around them. These "complaints" are inflammatory proteins called the senescence-associated secretory phenotype (SASP), which damage neighboring healthy cells and tissues.
Natural senolytics act like a fair but firm HR department that specifically identifies and removes these dysfunctional employees while leaving productive workers untouched. This selectivity is crucial. Random elimination of cells would cause more harm than good.
The Anti-Apoptotic Pathway Target
Senescent cells survive by upregulating anti-apoptotic (pro-survival) pathways. These include BCL-2, BCL-xL, PI3K/Akt, tyrosine kinases, HSP90, and FOXO4-p53 interactions.[Evidence: A][4] Natural senolytics disrupt these survival mechanisms, tipping senescent cells toward apoptosis (programmed cell death).
Specifically, quercetin and fisetin activate apoptosis and lethal autophagy through ERK inhibition and AMPK kinase activation.[Evidence: C][6] This dual mechanism, engaging both Type I (apoptosis) and Type II (autophagy) cell death pathways, makes flavonoid senolytics particularly effective.
Why Senescent Cells Are Vulnerable
Senescent cells accumulate high levels of copper and iron compared to healthy cells. This metal accumulation makes them uniquely susceptible to flavonoid-induced oxidative damage through prooxidant mechanisms.[Evidence: C][7] Healthy cells, with normal metal levels, remain protected from this oxidative assault.
Senolytics vs Senomorphics
Not all anti-aging compounds work the same way. Senolytics kill senescent cells, while senomorphics suppress the harmful SASP without eliminating the cells. For example, resveratrol exhibits senomorphic effects at low concentrations, activating SIRT1 pathways rather than inducing cell death.[Evidence: A][10] Procyanidin C1 demonstrates dual activity: low doses act as a senomorphic (inhibiting SASP), while high doses function as a senolytic (killing senescent cells via ROS).[Evidence: C][8]
Current research covers tyrosine kinase inhibitors, BCL-2 inhibitors, and natural polyphenols as potential senolytic agents, with AI-assisted drug discovery accelerating the identification of new compounds.[Evidence: A][5]
📊 Dosage and How to Use
Dosing protocols for natural senolytics differ significantly from typical daily supplements. Research supports intermittent "hit-and-run" administration rather than continuous daily use.[Evidence: A][4] This approach allows time for senescent cells to be cleared while minimizing potential side effects from constant exposure.
| Purpose/Condition | Compounds | Dosage | Duration/Protocol | Evidence |
|---|---|---|---|---|
| Senescent cell reduction (diabetic kidney disease) | Dasatinib + Quercetin | 100 mg + 1000 mg daily | 3 consecutive days | [B][1] |
| Idiopathic pulmonary fibrosis | Dasatinib + Quercetin | 100 mg + 1250 mg daily | 3 consecutive days/week for 3 weeks | [B][2] |
| Bone metabolism (postmenopausal women) | Dasatinib + Quercetin | 100 mg + 1000 mg daily | 20 weeks (intermittent) | [B][12] |
| Mild Alzheimer's disease (CNS penetration) | Dasatinib + Quercetin | 100 mg + 1000 mg daily | 12 weeks | [B][13] |
Important Dosing Considerations
- Intermittent protocol: The "hit-and-run" approach (3 consecutive days per cycle, then rest) is supported by Mayo Clinic research as the optimal strategy.[Evidence: A][4]
- Quercetin forms: Phytosome formulations may improve bioavailability compared to standard quercetin.
- Fisetin-only dosing: Human clinical protocols for fisetin alone are not yet established. Pilot studies have used varying doses, but optimal therapeutic dosing requires further research.
- Timing: Take with meals containing some fat to enhance absorption of these lipophilic compounds.
Note: All human trial dosing data involves the dasatinib plus quercetin (D+Q) combination. Dasatinib is a prescription medication requiring physician supervision. Natural senolytic-only protocols (fisetin, quercetin, or curcumin without dasatinib) lack established human clinical dosing.
⚠️ Risks, Side Effects, and Warnings
Side Effects from Clinical Trials
In Phase 1 trials of dasatinib plus quercetin in idiopathic pulmonary fibrosis patients, adverse events were primarily mild-to-moderate. Reported effects included sleep disturbances and anxiety.[Evidence: B][2] No serious adverse events related to treatment were reported in this trial.
The Phase 1 Alzheimer's trial reported that D+Q was safe and well-tolerated in 5 patients over 12 weeks.[Evidence: B][13] The Phase 2 bone metabolism trial in 60 postmenopausal women also demonstrated acceptable tolerability.[Evidence: B][12]
Potential Drug Interactions
Quercetin may interact with medications metabolized by cytochrome P450 enzymes. Inform your healthcare provider of all medications before starting supplementation. Specific interaction data for natural senolytics at senolytic doses requires additional research.
Contraindications
- Pregnancy and breastfeeding (insufficient safety data)
- Known allergy to flavonoid compounds
- Scheduled surgery within 2 weeks (quercetin may affect platelet function)
- Use of dasatinib or other tyrosine kinase inhibitors without physician supervision
Monitoring Recommendations
Monitor for adverse reactions during initial use. Consult your healthcare provider regularly when using senolytic supplements. Stop use and seek medical attention if you experience severe gastrointestinal symptoms, unusual bleeding, or allergic reactions.
🥗 Practical Ways to Use Natural Senolytics
How to Use This in Your Daily Life
Scenario 1: General Healthy Aging Support
- Compounds: Quercetin or fisetin supplements
- Protocol: Intermittent dosing (follow product recommendations)
- Timing: Take with meals containing dietary fat for improved absorption
- What to track: Energy levels, joint comfort, general wellbeing
- Realistic timeline: Benefits may take weeks to months of consistent intermittent use
Scenario 2: Research-Supported Protocol (Requires Medical Supervision)
- Compounds: Dasatinib + Quercetin (D+Q)[1]
- Dose: Dasatinib 100 mg + Quercetin 1000-1250 mg daily
- Duration: 3 consecutive days per cycle
- Population: Adults with specific age-related conditions under physician care
- What to track: Inflammatory markers, condition-specific outcomes
- Expected results: Reduced senescent cell burden markers[1]
Practical Integration
Take senolytic supplements with meals. Store supplements in a cool, dry place away from direct sunlight. Follow product label storage instructions. Consider phytosome quercetin formulations for potentially improved bioavailability.
Common Mistakes to Avoid
- Daily continuous dosing: Research supports intermittent "hit-and-run" protocols.[Evidence: A][4] Daily use may not be optimal and could increase side effect risk.
- Expecting immediate results: Senolytic effects involve gradual cellular clearance processes. Studies used treatment periods of weeks to months.[12][13]
- Using without medical guidance: Particularly for the D+Q combination, physician supervision is essential as dasatinib is a prescription medication.
- Relying on food sources alone: Therapeutic senolytic doses cannot be achieved through diet. Procyanidin C1 research used concentrated grape seed extracts, not dietary grape consumption.[8]
⚖️ Fisetin vs Quercetin: Which Is Better?
Fisetin and quercetin are the two most studied natural senolytic flavonoids. Both target anti-apoptotic pathways in senescent cells, but they have distinct characteristics worth considering.
| Feature | Fisetin | Quercetin |
|---|---|---|
| Senolytic Potency | Identified as most potent among 10 flavonoids tested[9] | Effective in combination with dasatinib; systematic review confirms cartilage benefits[15] |
| Human Clinical Trials | Preliminary pilot data only[14] | Multiple Phase 1-2 trials (with dasatinib)[1][2][12][13] |
| Primary Food Sources | Strawberries, apples, persimmons | Onions, capers, apples, berries |
| Mechanism | Prooxidant mechanism targeting metal-rich senescent cells[7] | ERK inhibition and AMPK activation[6] |
| Evidence Quality | Strong preclinical; limited human data | Stronger human evidence (in D+Q combination) |
| Meets Rigorous Senolytic Criteria | Yes[7] | Yes (with dasatinib)[7] |
Combination Approaches
Research suggests that only dasatinib plus quercetin and fisetin meet rigorous senolytic criteria in current literature.[Evidence: C][7] The D+Q combination has the most human clinical data. Fisetin demonstrates high preclinical potency but awaits larger human trials.
Other Natural Senolytic Compounds
Beyond fisetin and quercetin, research has identified additional natural senolytics:
- Procyanidin C1: From grape seed. Extended median lifespan 64.2% in aged mice with dual senomorphic/senolytic activity.[Evidence: C][8]
- Piperlongumine: From long pepper. Induced caspase-mediated apoptosis in senescent fibroblasts and showed synergy with navitoclax.[Evidence: C][11]
- Resveratrol: Acts as a senomorphic (SASP suppressor) rather than a true senolytic at typical doses. SIRT1 activation extends lifespan across multiple species, though bioavailability in humans is limited.[Evidence: A][10]
- Curcumin: From turmeric. Reviewed as potential senolytic with redox-sensitive properties.[Evidence: A][3]
- EGCG: From green tea. Included in comprehensive senolytic reviews as a natural polyphenol with anti-aging potential.[Evidence: A][5]
What The Evidence Shows (And Doesn't Show)
What Research Suggests
- Dasatinib plus quercetin reduced senescent cell markers (p16INK4A) by 35% in adipose tissue within 11 days in humans with diabetic kidney disease (n=9).[1]
- The D+Q combination penetrated the central nervous system, with dasatinib detected in cerebrospinal fluid in 80% of Alzheimer's patients (n=5).[13]
- Procyanidin C1 extended median post-treatment lifespan by 64.2% and overall lifespan by 9.4% in aged mice, demonstrating significant longevity potential in animal models.[8]
- Fisetin was identified as the most potent natural senolytic among 10 flavonoids tested, reducing senescence markers in multiple tissues in mice.[9]
- A systematic review and meta-analysis of 12 animal studies found quercetin significantly improved osteoarthritis cartilage scores.[15]
What's NOT Yet Proven
- Long-term human safety: Most human trials lasted 12 weeks or less. Multi-year safety profiles have not been established.
- Optimal dosing for natural senolytics alone: Human trials used D+Q combinations. Fisetin-only or quercetin-only therapeutic protocols lack established clinical dosing.
- Effects in healthy aging adults: Trials enrolled patients with specific conditions (diabetic kidney disease, IPF, Alzheimer's, postmenopausal osteoporosis). Benefits in healthy aging populations are extrapolated, not proven.
- Lifespan extension in humans: Animal lifespan data is promising[8][9] but human longevity effects remain undemonstrated.
- Individual response variability: Genetic factors affecting flavonoid metabolism (COMT, UGT, SULT polymorphisms) have not been characterized for senolytic response.
Where Caution Is Needed
- Phase 2 bone study: D+Q did not achieve its primary outcome of reducing bone resorption in postmenopausal women, though bone formation markers increased at early timepoints. Results suggest senescent cell burden may dictate clinical response.[12]
- Medication interactions: Quercetin affects cytochrome P450 enzymes. Dasatinib is a prescription medication with its own interaction profile. Medical supervision is essential for D+Q protocols.
- Evidence predominantly preclinical: Of 15 validated sources, only 4 are human trials (Level B). The overall evidence confidence score is 0.50 (below the 0.70 threshold), reflecting the emerging nature of this field.[14]
- Small sample sizes: Human trials enrolled 5-60 participants. Larger studies are needed to confirm effects and identify responders.
Should YOU Try This?
Best suited for: Adults over 50 with age-related conditions who have discussed senolytics with their healthcare provider and understand the preliminary nature of current evidence.
Not recommended for: Pregnant or breastfeeding women, individuals under 30 with no age-related concerns, those with bleeding disorders, individuals scheduled for surgery within 2 weeks, or anyone taking medications without consulting their prescriber about potential interactions.
Realistic timeline: Human trials used treatment periods of 3 days to 20 weeks. Effects on senescent cell markers were observed within 11 days in one trial.[1] Functional benefits may take longer to manifest. Individual response varies.
When to consult a professional: Before starting any senolytic protocol, especially if taking prescription medications, managing chronic health conditions, or considering the D+Q combination (which includes a prescription drug).
Frequently Asked Questions
When should you start taking senolytics?
Current research does not establish an optimal age to begin senolytic supplementation. Senescent cell accumulation accelerates with age, but younger individuals have lower senescent cell burdens. Clinical trials have enrolled participants over 50 years old with specific age-related conditions. Healthy younger adults may have minimal senescent cell burden, potentially limiting benefit. The Phase 2 bone metabolism trial enrolled postmenopausal women specifically. Consult a healthcare provider to evaluate whether senolytics are appropriate for your individual situation and health status.
What is the difference between fisetin and quercetin?
Both are flavonoid compounds with senolytic properties, but they differ in potency and evidence base. Fisetin was identified as the most potent senolytic among 10 flavonoids tested in preclinical screening, reducing senescence markers in multiple tissues and extending lifespan in both progeroid and wild-type mice. Quercetin has more human clinical data, but primarily in combination with the prescription drug dasatinib. The D+Q combination reduced senescent cell markers by 35% in humans and has been tested in IPF, Alzheimer's, and bone metabolism trials. Fisetin-only human data remains preliminary.
What is the best natural senolytic?
Based on preclinical data, fisetin demonstrated the highest potency among 10 flavonoids screened for senolytic activity, effectively reducing senescence markers across multiple tissues. However, human clinical evidence is strongest for the quercetin plus dasatinib combination, which has completed multiple Phase 1-2 trials demonstrating feasibility, tolerability, and senescent cell reduction. The 'best' choice depends on whether you prioritize preclinical potency (fisetin) or human trial evidence (quercetin in D+Q). Procyanidin C1 also shows promise with significant lifespan extension in mice.
Can you get enough senolytics from food?
No, foods do not contain therapeutic senolytic doses. Fisetin concentration in strawberries is approximately 160 µg per gram. To obtain a supplement-equivalent dose would require consuming an impractical quantity of strawberries daily. Procyanidin C1 research used concentrated grape seed extract at doses far exceeding what dietary grape consumption provides. While a Mediterranean-style diet rich in flavonoids may support general health, achieving senolytic effects requires supplementation with concentrated compounds. Food sources can contribute to overall polyphenol intake but cannot replace targeted senolytic supplementation.
What are the side effects of senolytics?
Clinical trials report natural senolytics as generally well-tolerated. In the Phase 1 IPF trial, adverse events from D+Q were primarily mild-to-moderate, including sleep disturbances and anxiety. No serious adverse events were attributed to treatment. The Alzheimer's trial found D+Q safe and well-tolerated over 12 weeks. The bone metabolism trial in postmenopausal women also reported acceptable safety. Long-term safety data beyond 6 months is limited. Individual responses may vary, and potential drug interactions exist. Monitor for adverse reactions and consult your healthcare provider.
How often should you take senolytics?
Research supports intermittent 'hit-and-run' dosing rather than daily continuous use. Human trials have used protocols of 3 consecutive days of treatment per cycle, with rest periods between cycles. The IPF trial administered D+Q for 3 consecutive days per week for 3 weeks. The bone metabolism trial used intermittent dosing over 20 weeks. This approach allows senescent cell clearance while minimizing prolonged compound exposure. The optimal cycle frequency for maintenance has not been established in long-term studies.
Are natural senolytics better than synthetic?
Natural and synthetic senolytics have different profiles. Natural senolytics (fisetin, quercetin) are more accessible and generally well-tolerated. Synthetic senolytics like navitoclax (ABT-263) are more potent but have significant side effects including thrombocytopenia. Dasatinib, a synthetic tyrosine kinase inhibitor, is combined with quercetin in most human trials because the combination appears more effective than either alone. Piperlongumine showed synergistic effects with navitoclax. The choice depends on the clinical context, with natural compounds preferred for general supplementation and pharmaceuticals reserved for supervised medical treatment.
What are senescent cells?
Senescent cells are damaged or aged cells that have permanently stopped dividing but resist normal cell death. Often called 'zombie cells,' they accumulate with age and secrete inflammatory proteins known as the senescence-associated secretory phenotype (SASP). This inflammatory secretion damages surrounding healthy tissues, contributing to chronic inflammation ('inflammaging') and age-related diseases. Senescent cells can arise from DNA damage, oxidative stress, telomere shortening, or oncogene activation. While cellular senescence initially serves as a tumor suppressor mechanism, accumulated senescent cells become harmful over time.
Can senolytics reverse aging?
Senolytics do not reverse aging but may address one contributor to age-related decline. In animal studies, procyanidin C1 extended median post-treatment lifespan by 64.2% in aged mice, and fisetin extended both median and maximum lifespan. Human trials show reduction of senescent cell markers and trends toward improved function. One study found fisetin showed potential mitigating effects on epigenetic age acceleration. However, aging is multifactorial, involving mechanisms beyond senescent cell accumulation. Senolytics target one pathway and should be viewed as one component of healthy aging, not a complete solution.
Our Accuracy Commitment and Editorial Principles
At Biochron, we take health information seriously. Every claim in this article is supported by peer-reviewed scientific evidence from reputable sources published in 2015 or later. We use a rigorous evidence-grading system to help you understand the strength of research behind each statement:
- [Evidence: A] = Systematic review or meta-analysis (strongest evidence)
- [Evidence: B] = Randomized controlled trial (RCT)
- [Evidence: C] = Cohort or case-control study
- [Evidence: D] = Expert opinion or clinical guideline
Our editorial team follows strict guidelines: we never exaggerate health claims, we clearly distinguish between correlation and causation, we update content regularly as new research emerges, and we transparently note when evidence is limited or conflicting. For our complete editorial standards, visit our Editorial Principles page.
This article is for informational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals before making changes to your health regimen, especially if you have medical conditions or take medications.
References
- 1 . Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease, Hickson LJ et al., EBioMedicine, 2019, 47:446-456. PubMed | DOI [Evidence: B]
- 2 . Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability, Nambiar A et al., EBioMedicine, 2023, 90:104481. PubMed | DOI [Evidence: B]
- 3 . Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases, Lagoumtzi SM, Chondrogianni N, Free Radical Biology and Medicine, 2021, 171:169-190. PubMed | DOI [Evidence: A]
- 4 . Senolytic drugs: from discovery to translation, Kirkland JL, Tchkonia T, Journal of Internal Medicine, 2020, 288(5):518-536. PubMed | DOI [Evidence: A]
- 5 . Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions, Saliev T, Singh PB, Biomolecules, 2025, 15(6):860. PubMed | DOI [Evidence: A]
- 6 . Senolytic Flavonoids Enhance Type-I and Type-II Cell Death in Human Radioresistant Colon Cancer Cells through AMPK/MAPK Pathway, Russo M et al., Cancers, 2023, 15(9):2660. PubMed | DOI [Evidence: C]
- 7 . Prospective Selective Mechanism of Emerging Senolytic Agents Derived from Flavonoids, Wang Y et al., Journal of Agricultural and Food Chemistry, 2021, 69(42):12418-12423. PubMed | DOI [Evidence: C]
- 8 . The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice, Xu Q et al., Nature Metabolism, 2021, 3(12):1706-1726. PubMed | DOI [Evidence: C]
- 9 . Fisetin is a senotherapeutic that extends health and lifespan, Yousefzadeh MJ et al., EBioMedicine, 2018, 36:18-28. PubMed | DOI [Evidence: C]
- 10 . SIRT1, resveratrol and aging, Rogina B, Tissenbaum HA, Frontiers in Genetics, 2024, 15:1393181. PubMed | DOI [Evidence: A]
- 11 . Discovery of piperlongumine as a potential novel lead for the development of senolytic agents, Wang Y et al., Aging, 2016, 8(11):2915-2926. PubMed | DOI [Evidence: C]
- 12 . Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial, Farr JN et al., Nature Medicine, 2024, 30(9):2605-2612. PubMed | DOI [Evidence: B]
- 13 . Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial, Gonzales MM et al., Nature Medicine, 2023, 29(10):2481-2488. PubMed | DOI [Evidence: B]
- 14 . Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions, Lee E et al., Aging, 2024, 16(4):3088-3106. PubMed | DOI [Evidence: C]
- 15 . Therapeutic potential of senolytic agent quercetin in osteoarthritis: A systematic review and meta-analysis of preclinical studies, Yamaura K et al., Ageing Research Reviews, 2023, 90:101989. PubMed | DOI [Evidence: A]
Medical Disclaimer
This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers are advised to consult their doctors or qualified health professionals regarding specific health questions and before making any changes to their health routine, including starting new supplements.
Neither Biochron nor the author takes responsibility for possible health consequences of any person reading or following the information in this educational content. All readers, especially those taking prescription medications, should consult their physicians before beginning any nutrition, supplement, or lifestyle program.
If you have a medical emergency, call your doctor or emergency services immediately.
